NR4A1 and neoplasm: In the multivariate analysis including pre-chemotherapy tumor size, nodal status, grading, hormone receptor status, C3M levels at baseline and changes in C3M levels between baseline and after four cycles of therapy, only C3M levels at baseline (p = 0.035, OR 4.469, 95%-CI 1.115–17.919) independently predicted pCR.